- About
- PsychU For You
- Topics
- Events
- Content
The Danger of Post-Traumatic Stress Disorder (PTSD) Stigma Among Marginalized Communities
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
The Danger of Post-Traumatic Stress Disorder (PTSD) Stigma Among Marginalized Communities
Marginalized communities are those excluded from mainstream social, economic, educational, and/or cultural life. Examples include race, age, sexual orientation, gender identity, physical ability, language and/or immigration status1. This webinar aims to raise awareness between post-traumatic stress disorder (PTSD) and the stigma associated with marginalized communities. A review of risk factors, challenges in identification, diagnosis, and treatment of PTSD in this community will be explored; followed by a discussion of barriers to accessing care and how healthcare professionals can improve these challenges in practice. Join us for an informative webinar moderated by Haneefa Rakeeb DNP, PMHNP-BC, RN alongside esteemed speakers Christiian Storm Credle, PsyD and Christopher Thomas Tobias, MS, MHA, CHFP, PA-C.
References: 1. Sevelius, J. M., et al. (2020). Research with Marginalized Communities: Challenges to Continuity During the COVID-19 Pandemic. AIDS and behavior, 24(7), 2009–2012. https://doi.org/10.1007/s10461-020-02920-3
Christiian Storm Credle, PsyD (he/him/his)
Director of Behavioral Health at Mazzoni Medical Center in Philadelphia, PA
Christopher Thomas Tobias, MS, MHA, CHFP, PA-C (he/him/his)
Director of Academic Education & Clinical Assistant Professor for Physician Studies at the School of Health Professions; Saint Joseph’s University, Philadelphia, PA
Haneefa Rakeeb, DNP, PMHNP-BC, AFN-BC (OPDC)
Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.
Disclaimers
Speakers Christtian Storm Credle, PsyD and Christopher Thomas Tobias, MS, MHA, CHFP, PA-C, are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Haneefa Rakeeb, DNP, PMHNP-BC, is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
March 2024 US.CORP.X.24.00068Registration
- PsychU For You
